Every week, Rinchem shares important articles and topics about chemical and gas logistics, industries we operate in, and the general global supply chain. In this week's review we discuss semiconductor education programs, the 2030 outlook on Pharma, and Super El Niño and supply chains.
Keep reading to see this week's hot topics.

UC San Diego Partners with TSMC to Create Pipeline From the Classroom to Semiconductor Cleanroom
In the article“UC San Diego Partners with TSMC to Create Pipeline From the Classroom to Semiconductor Cleanroom,” the university introduces a hands-on training program designed to prepare undergraduates from multiple disciplines for semiconductor manufacturing careers. Students begin with basic chip fabrication techniques using tabletop equipment before selected participants advance to specialized cleanroom training and faculty-led projects aligned with TSMC’s manufacturing activities. The program also provides a pathway to apply for internships at TSMC Arizona. By engaging students in chemistry, chemical engineering, mechanical engineering, and nanoengineering, the partnership highlights the diverse technical skills needed to manage fabrication processes, maintain complex machinery, and operate semiconductor facilities.

Pharma’s 2030 outlook: manufacturing, access and supply chain resilience
In the article “Pharma’s 2030 Outlook: Manufacturing, Access and Supply Chain Resilience,” industry panellists explore how pharmaceutical innovation must be supported by reliable manufacturing, sustainable pricing, and improved patient access. While targeted therapies and biosimilars could expand treatment options, commercial pressures on generic medicines and short purchasing contracts can discourage investment and increase shortage risks. The discussion highlights automation and continuous manufacturing as opportunities to strengthen Europe’s competitiveness, while AI and digital twins could accelerate development and improve production processes. Realising these benefits will require human oversight, trusted standards, and closer alignment between manufacturers, buyers, regulators, and healthcare policymakers.

Get more articles like this in your inbox
Sign up for our monthly newsletter
Find more articles
Request a Quote



